Curis, Inc. Stock Analysis & AI Score
Composite rating from 8 factors. Tap a factor to see the metrics behind its grade.
Company Information
| Employees | — |
| CEO | — |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | — |
| Website | — |
| Country | — |
| Exchange | NASDAQ |
SEC Filings
Annual Report (10-K)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
Quarterly Report (10-Q)
| Filing Date | Accepted | Link |
|---|---|---|
| Loading… | ||
ST Score
Curis, Inc. (CRIS) holds an ST Score of 18.2 out of 100 (D), with its strongest factor being Growth (B+) and its weakest Momentum (F). Analysts rate CRIS Buy across 18 ratings.
- Strongest
- GrowthB+
- Weakest
- MomentumF
All factor grades
- GrowthB+
- ValuationC
- ProfitabilityF
- Financial StrengthF
- MomentumF
- Piotroski0/9
Contact
CRIS stock: frequently asked questions
What is CRIS's ST Score?
Curis, Inc. (CRIS) has an ST Score of 18.2 out of 100, an overall grade of D. The ST Score combines eight factor grades — valuation, profitability, financial strength, momentum, growth, forecast, sentiment and Piotroski — into a single A+ to F rating.
Is CRIS a buy, sell, or hold?
Wall Street's consensus rating on CRIS is Buy based on 18 analyst ratings. Our own ST Score grades it D (18.2/100). This is data, not investment advice — always do your own research.
What is CRIS's valuation grade?
Curis, Inc. (CRIS) earns a valuation grade of C, measured against Biotechnology peers. The valuation factor looks at multiples such as P/E, P/S, P/B, EV/EBITDA and free cash flow yield.
What is CRIS's growth grade?
Curis, Inc. (CRIS) earns a growth grade of B+, measured against Biotechnology peers. The growth factor looks at revenue, earnings and cash flow growth over recent quarters and years.
What is CRIS's profitability grade?
Curis, Inc. (CRIS) earns a profitability grade of F, measured against Biotechnology peers. The profitability factor looks at margins and returns such as gross margin, net margin, ROE and ROIC.
What is CRIS's financial strength grade?
Curis, Inc. (CRIS) earns a financial strength grade of F, measured against Biotechnology peers. The financial strength factor looks at debt levels, liquidity and coverage ratios.
What is CRIS's Piotroski score?
Curis, Inc. (CRIS) has a Piotroski F-Score of 0 out of 9. The Piotroski score checks nine accounting signals covering profitability, leverage and operating efficiency; scores of 8–9 are considered strong and 0–2 weak.